An investigation for investors in NASDAQ:XENT shares was announced over possible securities laws violations by Intersect ENT and certain of its directors and officers.
Investors who purchased shares of Intersect ENT Inc (NASDAQ:XENT), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.
The investigation by a law firm focuses on whether a series of statements regarding Intersect ENT Inc’s business, its prospects and its operations were materially false and misleading at the time they were made.
Intersect ENT Inc reported that its annual Total Revenue rose from 38.59 per million in 2014 to $61.59 million in 2015 while its Net Loss increased from $18.36 million in 2014 to $26.63 million in 2015.
On November 2, 2016, Intersect ENT Inc reported its third quarter 2016 results and updated its 2016 outlook.
Shares of Intersect ENT Inc (NASDAQ:XENT) declined on November 2, 2016 to as low as $7.65 per share.
On November 29, 2016, NASDAQ:XENT shares closed at $10.75 per share.
Those who purchased NASDAQ:XENT shares have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com
Leave Your Comments